Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × Pemetrexed × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 90 Lung Neoplasms 34 Neoplasms 9 Neoplasm Metastasis 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Mesothelioma, Malignant 7 Colorectal Neoplasms 7 Carcinoma 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma 3 Colonic Neoplasms 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Ovarian Neoplasms 2 Non-Squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 NSCLC 2 Meningeal Carcinomatosis 2 Lung Diseases 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Biopsy 4 fludarabine 3 Cyclophosphamide 3 romidepsin 2 pembrolizumab 2 mogamulizumab 2 Specimen Handling 2 tazemetostat 1 talimogene laherparepvec 1 ruxolitinib 1 hypericin 1 fludarabine phosphate 1 cc-486 1 belinostat 1 Valganciclovir 1 Urine Specimen Collection 1 Therapeutics 1 TNTCFP protein 1 Spinal Puncture 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 MEDI-570 1 Light 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡